Details for New Drug Application (NDA): 017980
✉ Email this page to a colleague
The generic ingredient in MAZANOR is mazindol. Additional details are available on the mazindol profile page.
Summary for 017980
Tradename: | MAZANOR |
Applicant: | Wyeth Ayerst |
Ingredient: | mazindol |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017980
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017980
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Ayerst | MAZANOR | mazindol | TABLET;ORAL | 017980-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Ayerst | MAZANOR | mazindol | TABLET;ORAL | 017980-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription